The Valens Company Inc. (OTCMKTS:VLNCF) has announced that it will distribute specific products from its partner Verse Cannabis to Medical Cannabis by Shoppers™ platform. The company has selected specific products from every Verse Cannabis line, Verse Concentrates, and Verse Originals that Valens customs manufactures. It aims to bring its premium quality products to Canadian consumers at competitive prices.
Valens brings Verse Crumble and Verse Concentrates to consumers
Medical Cannabis by Shoppers will have Verse Crumble from Verse Concentrates product line derived from India White Rhino strain with myrcene, pinene, and caryophyllene terpenes which create piney and fruit aroma. The 1g product extracted using Valens’s hydrocarbon method features a range of cannabinoids with a honeycomb-like consistency. At around 75-80% THC, Verse crumble has been created to offer consumers an exceptional experience, and it is available in a non-reactive glass container to retain freshness. It is the company’s first crumble product and among the few concentrate products offered on Medical Cannabis by Shoppers platform.
Equally Medical Cannabis by Shoppers will offer a range of vape cartridges in different flavors and terpene-rich blends from the Verse Originals line. They Include Mandarin Mint, Tropic Lemon, Summer Berry, and Sunset Peach.
Valens delighted with market reception of Verse Cannabis products
Tyler Robson, Valens’ CEO and Founder, said that since the launch of Verse Cannabis products last year, their products have been outstanding in the Canadian recreational market because of their price point and quality even though they are available at few provincial retailers. He said that offering the products through a cannabis retail marketplace such as Medical Cannabis by Shoppers offers patients increased accessibility to Verse’s differentiated products.
Robson also said that they are delighted that Medical Cannabis by Shoppers has been encouraged by growing consumer demand witnessed for the products with other retailers. Most importantly, the rollout shows the strategic value that Valens will bring to partners by manufacturing excellence and a far-reaching distribution network. Following their partnership, Verse Cannabis and Valens expect to launch more cannabis product formats on Medical Cannabis by Shoppers, including pre-rolls and soft chews soon.
NewAge Inc. (NASDAQ:NBEV) Expanding Its Operations In Europe As Lucim™ Gets Recognition As A Safe Skincare Product
Post Views: 359 NewAge Inc. (NASDAQ:NBEV) announced a record net revenue increase in Europe, record attendance at its virtual events,...
ILUS International Inc. (OTCMKTS:ILUS) Appoints New Marketing Director Dejana Radonjic To Help With Global Marketing
Post Views: 320 ILUS International Inc. (OTCMKTS:ILUS) seems more focused on making new acquisitions, with about two accomplished within its...
Conservative Broadcast Media Journalism (OTCMKTS:CBMJ) Reports Revenues Of $2.4 Million In 2020
Post Views: 389 Conservative Broadcast Media Journalism (OTCMKTS:CBMJ) posted a robust growth of 118% YoY to $2.4 million in 2020. Development...
Cannabics Pharmaceuticals (OTCMKTS:CNBX) Initiates RCC-33 Dose-Response Study, And Cresco Labs (OTCMKTS:CRLBF) Launches Wonder Wellness Gummies
Post Views: 358 Cannabics Pharmaceuticals (OTCMKTS:CNBX) has announced that it will initiate a Dose-Response in-vivo Study in mice whose data...
Curaleaf Holdings Inc. (OTCMKTS:CURLF) Rebrands And Opens New Locations In Pennsylvania And Illinois
Post Views: 397 Curaleaf Holdings Inc. (OTCMKTS:CURLF) has announced new Curaleaf branding for its recently acquired retail locations and the...
Generex Biotechnology Corp’s (OTCMKTS:GNBT) NuGenerex Immuno-Oncology Responds To FDA Regarding Its Paediatric-Focused COVID-19 Vaccine
Post Views: 368 Generex Biotechnology Corp’s (OTCMKTS:GNBT) subsidiary NuGenerex Immuno-Oncology has announced the submission of a response to the FDA’s...